Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > I-Flow Donates Infection-Fighting Wound Care Product to Help Earthquake Victims in China

Abstract:
Company's Subsidiary, AcryMed, Responds to Plea from Chinese Partner; Ships Cases of SilvaSorb® Antimicrobial Gel to Quake Site With Help from Local FedEx

I-Flow Donates Infection-Fighting Wound Care Product to Help Earthquake Victims in China

LAKE FOREST, CA | Posted on May 20th, 2008

I-Flow Corporation (NASDAQ:IFLO), through its wholly-owned subsidiary AcryMed, announced today it has donated 1,000 tubes of its SilvaSorb antimicrobial gel product to the Red Cross of China for distribution to earthquake victims in Sichuan, China. The company offered its help last week by donating the available product and arranged for immediate shipping to China after a plea from its Chinese partner.

According to reports out of China, the recent earthquake has left thousands injured and created unclean conditions, raising fear of the spread of dangerous infections. AcryMed's SilvaSorb is a unique topical gel containing a highly effective silver antimicrobial compound that kills bacteria and fungus commonly associated with wounds and burns. Those who use it may significantly reduce the risk of contracting a life-threatening infection.

"Stemming the tide of infections will be critical to saving lives," said AcryMed's chief technology officer and founder, Bruce Gibbins, a microbiologist. "SilvaSorb is a gel that requires no training to apply and the antimicrobial technology it contains can have a significant impact on reducing life-threatening infections contracted by the wounded. We were glad to be able to assist the relief efforts."

Gibbins further commented, "Three years ago we were also able to assist Medical Teams International in helping the Tsunami victims in South Asia. As a company that is committed to helping those who really need it, we are proud to be able to contribute what we can."

SilvaSorb was recently cleared by the FDA for over the counter distribution and is available as a CVS brand anti-microbial silver gel in CVS/pharmacy stores throughout the United States. SilvaSorb is also distributed to medical professionals in the U.S. by Medline Industries.

####

About I-Flow Corporation
I-Flow Corporation (www.IFLO.com) is improving surgical outcomes by designing, developing and marketing technically-advanced, low-cost drug delivery systems and innovative surgical products for post-surgical pain relief and surgical site care.

AcryMed is a pioneering leader at the forefront of innovations in the fields of infection control and wound healing. The company’s SilvaSorb® products for advanced wound care and SilvaGard® nanoparticle surface treatment for medical devices are among the breakthrough technologies that have distinguished AcryMed as an industry leader. A wholly-owned subsidiary of I-Flow Corporation, AcryMed maintains on-site GMP/ISO certified manufacturing and lab facilities at its Beaverton, Oregon headquarters. For more information on AcryMed visit www.AcryMed.com.

For more information, please click here

Contacts:
I-Flow Corporation
Orlando Rodrigues
Vice President, Marketing
949-206-2619

or
Brenner Associates Public Relations
AcryMed
Brad Brenner
503-736-0610

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Maximum Precision in 3D Printing: New complete solution makes additive manufacturing standard for microfabrication February 26th, 2015

Real-time observation of bond formation by using femtosecond X-ray liquidography February 26th, 2015

Bruker-Sponsored Sixth AFM BioMed Conference Highlights Increasing Impact of AFM in Biological Applications February 26th, 2015

Graphene shows potential as novel anti-cancer therapeutic strategy: University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells February 26th, 2015

Nanomedicine

Graphene shows potential as novel anti-cancer therapeutic strategy: University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells February 26th, 2015

Cutting-edge technology optimizes cancer therapy with nanomedicine drug combinations: UCLA bioengineers develop platform that offers personalized approach to treatment February 24th, 2015

Optical nanoantennas set the stage for a NEMS lab-on-a-chip revolution February 24th, 2015

Together, nanotechnology and genetic interference may tackle 'untreatable' brain tumors: Tel Aviv University researchers' groundbreaking strategy stops brain tumor cell proliferation with targeted nanoparticles February 24th, 2015

Announcements

Maximum Precision in 3D Printing: New complete solution makes additive manufacturing standard for microfabrication February 26th, 2015

Real-time observation of bond formation by using femtosecond X-ray liquidography February 26th, 2015

Bruker-Sponsored Sixth AFM BioMed Conference Highlights Increasing Impact of AFM in Biological Applications February 26th, 2015

Graphene shows potential as novel anti-cancer therapeutic strategy: University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells February 26th, 2015

Human Interest/Art

2015 Nanonics Image Contest January 29th, 2015

OCSiAl supports NanoART Imagery Contest January 23rd, 2015

EnvisioNano: An image contest hosted by the National Nanotechnology Initiative (NNI) January 22nd, 2015

Oxford Instruments Asylum Research Announces AFM Image Contest Winners January 11th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE